Document is current
Any future updates will be listed below
-
Authors
Chuang, Chien-Chia
Braham-Chaouche, Lydia
Thomas, Ryan
Mnif, Tarek
-
Funding
Funding for this research was provided by:
Sanofi
Regeneron Pharmaceuticals
- License Information
-
More Information
Article History
Received: 23 October 2024
Accepted: 27 March 2025
First Online: 17 April 2025
Declarations
:
: Chien-Chia Chuang is an employee and stockholder of Sanofi. Lydia Braham-Chaouche and Tarek Mnif are employees of Cerner Enviza, which received funding for this analysis from Sanofi and Regeneron Pharmaceuticals Inc. Ryan Thomas is an employee and stockholder of Regeneron Pharmaceuticals Inc.
: No personal data were collected from the survey and no medical information was abstracted from the patient medical records; therefore, approval of the study by central and/or local ethical committees in China was not required. The research complied with GDPR and all international/local data protection legislations and Insights Association/EphMRA/BHBIA.
